0000728079-16-000003.txt : 20160106
0000728079-16-000003.hdr.sgml : 20160106
20160106124840
ACCESSION NUMBER: 0000728079-16-000003
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20160106
DATE AS OF CHANGE: 20160106
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-88114
FILM NUMBER: 161326056
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: FORESTERS INVESTMENT MANAGEMENT COMPANY, INC.
CENTRAL INDEX KEY: 0000728079
IRS NUMBER: 136120357
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 40 WALL STREET
STREET 2: 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10005-1343
BUSINESS PHONE: 212-858-8000
MAIL ADDRESS:
STREET 1: 40 WALL STREET
STREET 2: 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10005-1343
FORMER COMPANY:
FORMER CONFORMED NAME: FIRST INVESTORS MANAGEMENT CO INC
DATE OF NAME CHANGE: 19960206
SC 13G
1
13gphibroanimalhealth.txt
PHIBRO ANIMAL HEALTH CORP.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
__________________________________________________
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. __)
Phibro Animal Health Corporation
___________________________________________________
(Name of Issuer)
Common Stock
___________________________________________________
(Title of Class of Securities)
71742Q106
___________________________________________________
(CUSIP Number)
December 31, 2015
___________________________________________________
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
|X| Rule 13d-1(b)
|_| Rule 13d-1(c)
|_| Rule 13d-1(d)
CUSIP No. 71742Q106
1 Name of Reporting Persons
Foresters Investment Management Company, Inc.
2 Check the Appropriate Box if a Member of a Group
(a)
(b)
3 SEC Use Only
4 Citizen Or Place Of Organization
Foresters Investment Management Company, Inc.
40 Wall Street - 10th Floor
New York, New York 10005
Number of 5 Sole Voting Power
Shares 971,395
Beneficially 6 Shared Voting Power
Owned By 0
Each 7 Sole Dispositive Power
Reporting 971,395
Person With: 8 Shared Dispositive Power
0
9 Aggregate Amount Beneficially Owned By Each Reporting Person
971,395
10 Check If The Aggregate Amount In Row (9) Excludes Certain Shares
N/A
11 Percent Of Class Represented By Amount In Row 9
5.4%
12 Type Of Reporting Person
IV
Item 1.
(a) Name of Issuer:
Phibro Animal Health Corporation
(b) Address of Issuer's Principal Executive Offices:
Phibro Animal Health Corporation
Glenpointe Center East, 3rd Floor
300 Frank W. Burr Blvd., Ste. 21
Teaneck, NJ 07666-6712
Item 2.
(a) Name of Person Filing
Foresters Investment Management Company, Inc.
(b) Address of Principal Business Office, or, if none, Residence
Foresters Investment Management Company, Inc.
40 Wall Street - 10th Floor
New York, New York 10005
(c) Citizenship
United States
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number
71742Q106
Item 3. If this statement is filed pursuant to Sections 240.13d-1(b)
or (c), check whether the person filing is:
(a) |_| Broker or dealer registered under section 15 of the Act
(14 U.S.C. 78o).
(b) |_| Bank as defined in section 3(a)(6) of the Act
(15 U.S.C. 78c).
(c) |_| Insurance company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c).
(d) |X| Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) |_| An investment adviser in accordance with
Section 40.13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance
with Section 240.13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance
with Section 240.13d-1(b)(1)(ii)(G);
(h) |_| A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) |_| A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) |_| Group, in accordance with Section 240.13d-1(b)(1)(ii)(J);
Item 4. Ownership
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer
identified in Item 1.
(a) Amount beneficially owned: 971,395
(b) Percent of class: 5.4%
(c) Number of shares as to which the person has:
i. Sole power to vote or to direct the vote: 971,395
ii. Shared power to vote or to direct the vote: 0
iii. Sole power to dispose or to direct the disposition of: 971,395
iv. Shared power to dispose or to direct the disposition of: 0
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percont of the class of
securities, check the following [ ].
Item 6. Ownership of More than Five Percent on Behalf of Another
Person N/A
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Holding Company N/A
Item 8. Identification and Classification of Members of the Group N/A
Item 9. Notice of Dissolution of Group N/A
Item 10. Certification
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held in
the ordinary course of business and were not acquired and are not held
for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction
having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
January 6, 2016
______________________
Date
/S/ MARC S. MILGRAM
________________________
Signature
Marc S. Milgram
Chief Compliance Officer
________________________
Name/Title